These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25816097)

  • 1. C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model.
    Kim HM; Lee ES; Lee BR; Yadav D; Kim YM; Ko HJ; Park KS; Lee EY; Chung CH
    PLoS One; 2015; 10(3):e0120711. PubMed ID: 25816097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.
    Tamura Y; Sugimoto M; Murayama T; Ueda Y; Kanamori H; Ono K; Ariyasu H; Akamizu T; Kita T; Yokode M; Arai H
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2195-201. PubMed ID: 18818420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.
    Legry V; Van Rooyen DM; Lambert B; Sempoux C; Poekes L; Español-Suñer R; Molendi-Coste O; Horsmans Y; Farrell GC; Leclercq IA
    Clin Sci (Lond); 2014 Oct; 127(7):507-18. PubMed ID: 24766485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db/db mice.
    Fukuda M; Nakamura T; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yasuda O; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2010 Oct; 335(1):70-5. PubMed ID: 20651026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
    Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
    Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.
    Tamura Y; Sugimoto M; Murayama T; Minami M; Nishikaze Y; Ariyasu H; Akamizu T; Kita T; Yokode M; Arai H
    J Atheroscler Thromb; 2010 Mar; 17(3):219-28. PubMed ID: 20179360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
    Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CYP4A reduces hepatic endoplasmic reticulum stress and features of diabetes in mice.
    Park EC; Kim SI; Hong Y; Hwang JW; Cho GS; Cha HN; Han JK; Yun CH; Park SY; Jang IS; Lee ZW; Choi JS; Kim S; Kim GH
    Gastroenterology; 2014 Oct; 147(4):860-9. PubMed ID: 24983671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
    Tahara A; Kurosaki E; Yokono M; Yamajuku D; Kihara R; Hayashizaki Y; Takasu T; Imamura M; Li Q; Tomiyama H; Kobayashi Y; Noda A; Sasamata M; Shibasaki M
    Eur J Pharmacol; 2013 Sep; 715(1-3):246-55. PubMed ID: 23707905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
    PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.
    Yang SJ; IglayReger HB; Kadouh HC; Bodary PF
    Diabetologia; 2009 May; 52(5):972-81. PubMed ID: 19277603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db mice.
    Park HJ; Jung UJ; Cho SJ; Jung HK; Shim S; Choi MS
    J Nutr Biochem; 2013 Feb; 24(2):419-27. PubMed ID: 22694954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Linolenic Acid-Enriched Cold-Pressed Perilla Oil Suppress High-Fat Diet-Induced Hepatic Steatosis through Amelioration of the ER Stress-Mediated Autophagy.
    Bae SJ; Kim JE; Choi HJ; Choi YJ; Lee SJ; Gong JE; Seo S; Yang SY; An BS; Lee HS; Kim DS; Lee CY; Hwang DY
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32521713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
    Kim DY; Kim SR; Jung UJ
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
    Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
    PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atf6α-null mice are glucose intolerant due to pancreatic β-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance.
    Usui M; Yamaguchi S; Tanji Y; Tominaga R; Ishigaki Y; Fukumoto M; Katagiri H; Mori K; Oka Y; Ishihara H
    Metabolism; 2012 Aug; 61(8):1118-28. PubMed ID: 22386934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.